Cormorant Asset Management LP 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:11 pm Sale |
2021-12-31 | 13G | C4 Therapeutics, Inc. CCCC |
Cormorant Asset Management LP | 0 0.000% |
-2,490,065 (Position Closed) |
Filing |
| 2021-02-16 3:03 pm Sale |
2020-12-31 | 13G | C4 Therapeutics, Inc. CCCC |
Cormorant Asset Management LP | 2,490,065 5.790% |
-3 (-0.00%) |
Filing |
| 2020-10-16 4:00 pm Purchase |
2020-10-06 | 13G | C4 Therapeutics, Inc. CCCC |
Cormorant Asset Management LP | 2,490,068 5.790% |
2,490,068 (New Position) |
Filing |